Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in CanadaLauren Curry, Maryam Soleimani, Jeffrey Graham et al.|Journal of Geriatric Oncology|2026Cited by 0
Head-to-head comparison of pembrolizumab-axitinib versus pembrolizumab-lenvatinib in metastatic RCC: Real world data from the Canadian Kidney Cancer Information System (CKCis) database.Alexandre da Silva Faco, Ramy Saleh, Mohammad Amin Salehi et al.|Journal of Clinical Oncology|2026Cited by 0
Outcomes of delayed cytoreductive nephrectomy in patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint inhibitor therapy.Mohamed Soufi, Jeffrey Graham, Sunita Ghosh et al.|Journal of Clinical Oncology|2026Cited by 0
Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World AnalysisBraden Millan, Aly‐Khan A. Lalani, Sunita Ghosh et al.|Clinical Genitourinary Cancer|2026Cited by 0